Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Juan Carlos Rubilar MSc"'
Autor:
Mario Rojo MSc, Angela Margarita Roco PhD, Marcelo Suarez MSc, Maria Alejandra Lavanderos PhD, Gabriel Verón MSc, Maria Paz Bertoglia PhD, Annabella Arredondo MD, Elena Nieto MD, Juan Carlos Rubilar MSc, Francisca Tamayo PCh, Daniela Cruz MSc, Jessica Muñoz MSc, Gabriela Bravo MSc, Patricio Salas MD, Fanny Mejías MD, Paulo Véliz MSc, Gerald Godoy MSc, Nelson Miguel Varela PhD, G. Llull MSc, Luis Abel Quiñones PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Despite the development of new oral agents over the last decade, vitamin K antagonists (VKAs) remain the most widely used anticoagulants for treating and preventing thromboembolism worldwide. In Chile, the Ministry of Health indicates that acenocouma
Externí odkaz:
https://doaj.org/article/b3dbe867447c497f89dcb22acc4925d3
Autor:
Elena Nieto MD, Marcelo Suarez MSc, Ángela Roco PhD, Juan Carlos Rubilar MSc, Francisca Tamayo PCh, Mario Rojo MSc, Gabriel Verón MSc, Juliana Sepúlveda MD, Fanny Mejías MD, Patricio Salas MD, María Góngora MD, Patricio Andrade MD, Alicia Canales MD, Jorge Carabantes MD, Daniela Cruz MSc, Emma Contreras MSc, Daniela Pavez MSc, Paulina Charo MSc, Gabriela Bravo MSc, Juan Calderón MSc, Carlos Gallardo MD, Patricia Vega MSc, Luis A. Quiñones PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Warfarin and acenocoumarol are used in various cardiovascular disorders to improve the prognosis of patients with thromboembolic disease. However, there is a lack of substantial efficacy and safety data on antithrombotic prophylaxis in several countr
Externí odkaz:
https://doaj.org/article/4784ba20189a48229162fc4ca0c1e138